002349 Jinghua Pharmaceutical Group
- 8.00
- +0.62+8.40%
Jinghua Pharmaceutical Group News
Jinghua Pharmaceutical Group: Announcement Regarding the Independent Director Candidate Receiving the Qualification Certificate of Independent Director.
Jinghua Pharmaceutical Group: Announcement regarding the consistency evaluation of the company's product phenobarbital tablets as generic drugs.
Jinghua Pharmaceutical Group: Announcement of Resolutions of the First Meeting of the Sixth Board of Directors
Jinghua Pharmaceutical Group: Announcement of Resolutions of the First Meeting of the Sixth Board of Supervisors
Jinghua Pharmaceutical Group: 002349 Jinghua Pharmaceutical Investor Relations Management Information 20240510
Jinghua Pharmaceutical: 2023 Independent Director Debriefing Report (Ma Ling)
Jinghua Pharmaceutical: Letter of commitment from an independent director candidate to participate in independent director training and obtain an independent director qualification certificate
Jinghua Pharmaceutical: Independent Director Nominee Statement and Commitment (Zhang Xiaomei)
Jinghua Pharmaceutical: Board of Directors Special Opinions on Independent Directors' Independence Assessment
Jinghua Pharmaceutical: 2023 Independent Director Debriefing Report (Feng Qiaogen)
Jinghua Pharmaceutical: 2023 Supervisory Committee Work Report
Jinghua Pharmaceutical: Self-inspection report on the independence of independent directors
Jinghua Pharmaceutical: The company's assessment report on the performance of accounting firms in 2023
Jinghua Pharmaceutical: Independent Director Candidate Statement and Commitment (Wang Xu)
Jinghua Pharmaceutical: Independent Director Nominee Statement and Commitment (Liu Jing)
Jinghua Pharmaceutical: Internal Control Audit Report
Jinghua Pharmaceutical: Announcement of Board Resolutions
Jinghua Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Jinghua Pharmaceutical: Independent Director Nominee Statement and Commitment (Wang Xu)
Jinghua Pharmaceutical: 2023 Annual Audit Report
Analysis
Price Target
No Data
No Data